Nikolaos Syrigos

926 total citations
61 papers, 599 citations indexed

About

Nikolaos Syrigos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Nikolaos Syrigos has authored 61 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 9 papers in Infectious Diseases. Recurrent topics in Nikolaos Syrigos's work include Cancer Immunotherapy and Biomarkers (11 papers), COVID-19 Clinical Research Studies (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Nikolaos Syrigos is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), COVID-19 Clinical Research Studies (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Nikolaos Syrigos collaborates with scholars based in Greece, United States and China. Nikolaos Syrigos's co-authors include Ηλίας Κοττέας, Georgia Gomatou, Ioannis Vathiotis, Ioannis P. Trontzas, Andriani Charpidou, Ioannis Gkiozos, Edward Chu, Jun Li, Cheng Fang and Ning Wei and has published in prestigious journals such as Oncogene, International Journal of Molecular Sciences and Journal of Allergy and Clinical Immunology.

In The Last Decade

Nikolaos Syrigos

54 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nikolaos Syrigos Greece	12	279	190	187	91	76	61	599
Shinichiro Shimamatsu Japan	12	352 1.3×	277 1.5×	175 0.9×	89 1.0×	92 1.2×	40	580
Zhixin Qiu China	20	216 0.8×	199 1.0×	333 1.8×	133 1.5×	147 1.9×	49	790
Fernanda I. Arnaldez United States	11	196 0.7×	110 0.6×	202 1.1×	84 0.9×	60 0.8×	20	513
Youwei Bi United States	14	275 1.0×	307 1.6×	225 1.2×	89 1.0×	55 0.7×	25	768
Ofer Margalit Israel	15	382 1.4×	127 0.7×	330 1.8×	209 2.3×	67 0.9×	52	824
Mateusz Olbromski Poland	15	242 0.9×	136 0.7×	354 1.9×	170 1.9×	116 1.5×	43	717
Tianli Zhang China	14	294 1.1×	274 1.4×	236 1.3×	106 1.2×	57 0.8×	24	638
Luis A. Martinez United States	11	423 1.5×	205 1.1×	366 2.0×	172 1.9×	212 2.8×	17	868
Yongfeng Ding China	18	409 1.5×	213 1.1×	305 1.6×	150 1.6×	231 3.0×	51	944
Cristina Pérez-Ramírez Spain	14	211 0.8×	161 0.8×	309 1.7×	177 1.9×	108 1.4×	50	762

Countries citing papers authored by Nikolaos Syrigos

Since Specialization

Citations

This map shows the geographic impact of Nikolaos Syrigos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaos Syrigos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaos Syrigos more than expected).

Fields of papers citing papers by Nikolaos Syrigos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolaos Syrigos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaos Syrigos. The network helps show where Nikolaos Syrigos may publish in the future.

Co-authorship network of co-authors of Nikolaos Syrigos

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolaos Syrigos. A scholar is included among the top collaborators of Nikolaos Syrigos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolaos Syrigos. Nikolaos Syrigos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Κοττέας, Ηλίας, Dimitra Stefanou, Helen Gogas, et al.. (2025). Real-world safety and efficacy of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive/HER2-low metastatic breast cancer: a multicenter retrospective cohort study. Future Oncology. 21(24). 3189–3196. 1 indexed citations

Syrigos, Nikolaos, et al.. (2025). Breaking Through: Immunotherapy Innovations in Pleural Mesothelioma. Clinical Lung Cancer. 26(6). 458–469.

Trontzas, Ioannis P., et al.. (2025). Persistent Liver Manifestations in Allopurinol-Induced Sweet’s Syndrome: An Uncommon Case Report. Journal of Clinical Medicine. 14(20). 7186–7186.

Syrigos, Nikolaos, et al.. (2024). Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments. Cancers. 16(7). 1414–1414. 7 indexed citations

Syrigos, Nikolaos, et al.. (2024). The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature. Monaldi Archives for Chest Disease. 95(3).

Syrigos, Nikolaos, Anna Zygogianni, Ioannis Georgakopoulos, et al.. (2024). Comprehensive 3DCRT Hypofractionated Radiotherapy Schedule for Localized Prostate Adenocarcinoma in the Era of IMRT: Dosimetric and Endoscopic Analysis. Cancers. 16(6). 1192–1192. 1 indexed citations

Lanitis, Sophocles, et al.. (2024). Mutations Matter: Unravelling the Genetic Blueprint of Invasive Lobular Carcinoma for Progression Insights and Treatment Strategies. Cancers. 16(22). 3826–3826. 2 indexed citations

Dardavesis, Theodoros, et al.. (2024). Chatbots in Cancer Applications, Advantages and Disadvantages: All that Glitters Is Not Gold. Journal of Personalized Medicine. 14(8). 877–877. 11 indexed citations

Stefanou, Dimitra, et al.. (2024). Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study. Cancers. 16(7). 1442–1442.

10.

Fiste, Oraianthi, Ioannis Gkiozos, Andriani Charpidou, & Nikolaos Syrigos. (2024). Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC. Cancers. 16(4). 831–831. 20 indexed citations

11.

Charpidou, Andriani, et al.. (2024). Predictive Value of Serum VEGF Levels in Non-Small Cell Lung Cancer: A Review. Preprints.org. 1 indexed citations

12.

Gomatou, Georgia, et al.. (2023). The Role of REV-ERB Receptors in Cancer Pathogenesis. International Journal of Molecular Sciences. 24(10). 8980–8980. 7 indexed citations

13.

Vamvakaris, Ioannis, et al.. (2023). Pulmonary benign metastasizing leiomyoma: A case report. Monaldi Archives for Chest Disease. 94(1). 1 indexed citations

14.

Gomatou, Georgia, Nikolaos Syrigos, & Ηλίας Κοττέας. (2023). Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options. Cancers. 15(3). 841–841. 77 indexed citations

15.

Rapti, Vasiliki, Θωμάς Τσαγανός, Ioannis Vathiotis, et al.. (2022). New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?. Vaccines. 10(10). 1607–1607. 10 indexed citations

16.

Petrakis, Vasileios, Vasiliki Rapti, Karolina Akinosoglou, et al.. (2022). Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia. Microorganisms. 10(10). 1949–1949. 4 indexed citations

17.

Trontzas, Ioannis P., et al.. (2022). Immune Checkpoint Blockade in Hormone Receptor-Positive Breast Cancer: Resistance Mechanisms and Future Perspectives. Clinical Breast Cancer. 22(7). 642–649. 7 indexed citations

18.

Syrigos, Nikolaos, et al.. (2022). CD24: A Novel Target for Cancer Immunotherapy. Journal of Personalized Medicine. 12(8). 1235–1235. 61 indexed citations

19.

Gomatou, Georgia, et al.. (2021). Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors. Molecular Biology Reports. 48(1). 915–925. 27 indexed citations

20.

Simantiris, Spyridon, et al.. (2019). The role of kisspeptin system in cancer biology. Critical Reviews in Oncology/Hematology. 142. 130–140. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact